Benzinga | May 25, 2021 07:23AM EDT

Evercore ISI Group Initiates Coverage On Werewolf Therapeutics with Outperform Rating, Announces Price Target of $23

Evercore ISI Group analyst Maneka Mirchandaney initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Outperform rating and announces Price Target of $23.